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CASE REPORT
INTRODUCTION
Cancer of the esophagus is relatively uncommon,
but it is the eighth most common cancers worldwide
(4.2%). The incidence of esophageal cancer is
differs in different countries. A 20-fold variation is
observed between high-risk in China and low-risk in
Western Africa. The incidence for men and women
per 100,000 population are 27.4 : 12.0 in China and
1.3 : 0.6 in Western Africa. The incidence in
South-Eastern Asia is 3.1 : 1.2 per 100,000 population
for men and women. Esophageal cancer is more
common in men than in women; in most areas, the sex
ratio is 7:1.1
Most esophageal cancers are found in two distinct
histopathological types, i.e. squamous cell carcinoma
and adenocarcinoma. Several rare cancers of
the esophagus have been described, including adenoid
cystic carcinoma. This neoplasm is indistinguishable
clinically and prognostically from the more common
types of esophageal carcinoma.2 Here we report
a female patient with adenoid cystic carcinoma and
the diagnostic work-up.
CASE REPORT
A woman, 76 years old, came to hospital presented
with dysphagia since the last 3 months. She also
reported 10 kg weight loss in the past 3 months. Last
week, she also felt pain when swallowing food and
nausea but not vomiting. On physical examination,
the patient was pale and thin. Vital signs were normal.
No abnormalities found on chest, abdominal and nodes
examination. No liver enlargement.
The problems of the patient were dysphagia, weight
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loss, odynophagia, and dyspepsia. At that time
the differential diagnoses were malignancy of upper
gastrointestinal tract, achalasia, Zenker’s diverticle,
esophageal spasm and esophageal dismotility. Routine
blood tests were normal except erythrocyte
sedimentation rate (ESR) = 105 mm/hr (Westergreen).
LDH was 336 U/L.
Patient was asked to undergo upper gastro-
intestinal tract endoscopy. On examination, the scope
could only be inserted into the middle third of
the esophagus. There is luminal narrowing but
intraluminal mucous appearance was normal
(see figure 1).
Esophagography with barium swallow showed
a marked stenosis of the middle third of the esophagus
(figure 2). Abdominal ultrasonography showed mild
hepatomegaly but no mass. CT scanning of the thorax
showed a diffuse circular thickness in the middle third
of esophagus with luminal stenosis and infiltration to
middle mediastinum (figure 3). Other organs were
normal. Therefore, it was suspected that the patient
had limphadenopaty (subcarinal) which extend to
the upper right hyllus.
  
Figure 1. Intraluminal narrowing of the middle third of
the esophagus
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The next management of the patient was
esophageal dilatation with Savary-Guillard dilatator
5 Fr to 14 Fr. Afterwards, the patient was planned to
undergo esophagogastroduodenoscopy (EGD) biopsy
and esophageal ultrasonography (EUS) guided biopsy
or bronchoscopy with subcarinal fine-needle
aspiration (FNA) biopsy.
EGD biopsy was done after successful dilatation
of the esophagus, but no abnormality found in
the mucosa of the esophagus and anthrum either
macroscopically or histopathologically. Because of
limited facility in our hospital and the patient’s
preference, she was sent to Singapore where she
underwent EUS-guided biopsy and bronchoscopy with
subcarinal FNA biopsy. Histopathological report from
EUS only found non-specific mild reactive changes,
which might be due to the under-representative
specimens of more deeply seated pathology.
In addition, the access for biopsy was difficult due to
the mass in the middle third of the esophagus.
Histopathology report from subcarinal FNA biopsy
confirmed a diagnosis of adenoid cystic carcinoma.
Approximately one month after the patient returned
to our hospital, she was re-hospitalized due to
progressive dysphagia, decreasing appetite and more
weight loss. There was again a narrowing of the middle
third of the esophagus and she underwent a second
esophageal dilatation to 14 Fr. Magnetic Resonance
Imaging (MRI) of the thorax showed a tumor mass in
the middle of mediastinum which surrounds and
compresses the esopagheal lumen. There were
multiple vertebral metastases in cervical, thoracal and
lumbal vertebrae. Several multiple coin lesions were
also seen in the liver. The patient was diagnosed as
adenoid cystic carcinoma of the esophagus stage IV
(T4N1M1). Palliative radiotherapy was then scheduled
for 12 times at the dose of 250 cGy for each schedule.
After radiation, the patient developed progressive
disease with bone, lung, and liver metastases.
She received one dose of paclitaxel, but she died
4 months after the completion of radiation therapy or
less than 8 months after the first admission.
DISCUSSION
In this report we present an extremely rare type of
esophageal cancer. There is not much publication about
adenoid cystic carcinoma of the esophagus. There are
only about 60 cases have been published in
the literature so far. One large study involving 2,454
esophageal carcinoma treated between 1949 and 1991
found only 30 cases of unusual variants, among which,
adenoid cystic carcinoma was found in only 2 patients
(0.08%).3 Data from Japanese Society for Esophageal
Disease 1995-1997 found only 3 cases out of 1,948
esophageal cancers (0.15%).4
Dysphagia was the only complain of the patient
when she came. Most patients with adenoid cystic
carcinoma of the esophagus present with dysphagia,
but other symptoms might also present such as
retrosternal chest pain, nausea and vomiting, and post
prandial epigastric fullness.5 Progressive dysphagia was
reported in a patient.6 The average duration of
symptoms is three months before presentation.7
The disease was also reported to be found after being
treated for craniopharyngioma8 and incidentally during
an examination of cholelithiasis.9
The narrowing of esophageal lumen seen by
endoscopy suggested a tumor or another cause. It is
supported by the radiographic examination and
CT scanning. However, it was difficult to know whether
the mass was originated from the esophagus or lymph
node. By endosonography, adenoid cystic carcinoma
of the esophagus is isoechoic and primarily
submucosal.5 Most of the reported tumors were found
in the middle third of the esophagus.10,11 Our patient
also has sub-mucosal tumor which was located in the
middle third of the esophagus.
Histopathological confirmation was difficult due to
the presence of esophageal stenosis. EGD and
EUS-guided biopsy showed only normal mucosae of
the esophagus and anthrum. In fact, the tumor might
be covered by normal esophageal epithelium, but
 localized entirely in the submucosal layer.9
An alternative approach to perform subcarinal biopsy
through bronchoscopy has not been reported in
previous publications. Most definitive diagnosis could
be made only after tumor removal (subtotal
esophagectomy).12 In this report, preliminary biopsy
suggested poorly differentiated adenocarcinoma but
after resection, it was confirmed to adenoid cystic
 
Figure 3. Diffuse circular thickness in the middle third of
the esophagus
 
 
Figure 2. The narrowing of the middle third of the esophagus
Volume 7, Number 2,  August  2006 53
Adenoid Cystic carcinoma of the Esopagus
 carcinoma which histologically contained basaloid cells,
cribiform foci, and a certain amount of eosinophilic
hyaline substance.
This type of cancer commonly originates in
the major salivary glands and respiratory tract.13
Histologically, it is similar to adenoid cystic carcinoma
and mucoepidermoid carcinomas of the salivary
glands14 and it is believed to arise from
the submucosal gland.15 This might explain
the appearance of normal mucosa on endoscopy and
biopsy.
The disease has more aggressive behavior that
differs from the same tumor of the salivary glands and
other organ.16 Surgical resection (esophagectomy) is
the standard therapy in localized disease, while
radiotherapy and/or chemotherapy is the predominate
treatment in the advanced stage. However, all these
modality of treatments have no consistent effect on
survival. The 5-year survival rate of this malignancy is
5-10% with the median survival time of approximately
nine months.5
CONCLUSION
Adenoid cystic carcinoma of the esophagus is
a very rare case and might not be diagnosed without
advanced modalities. Dysphagia and esophageal
narrowing could be the main signs and symptoms, but
a histopathological confirmation is required. The delay
of diagnosis could affect the patient’s management.
Unfortunately, the disease characteristically exhibits a
clinically aggressive behavior with short survival time.
Further studies are needed to elucidate treatment
options in this unusual variant of esophageal cancer.
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